| Literature DB >> 22343234 |
Leigh G Seamon1, Debra L Richardson, Larry J Copeland.
Abstract
This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).Entities:
Mesh：
Substances：
Year: 2012 PMID： 22343234 DOI： 10.1097/GRF.0b013e318248050d
Source DB: PubMed Journal: Clin Obstet Gynecol ISSN： 0009-9201 Impact factor: 2.190